Why the study?
Does moxonidine, hydrochlorothiazide, or their combination reduce blood pressure in patients with mild-to-moderate hypertension compared to placebo?
Does moxonidine, hydrochlorothiazide, or their combination reduce blood pressure in patients with mild-to-moderate hypertension compared to placebo?
The combination of moxonidine and hydrochlorothiazide significantly improves antihypertensive efficacy compared to monotherapy without compromising safety.
No takes yet. Share an insight, caveat, or question.
Supports combination moxonidine-hydrochlorothiazide for superior response rates; confirms additive efficacy over monotherapies in mild-to-moderate hypertension.
Frei et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: